Avelumab Alone or in Combination With Chemotherapy vs Chemotherapy Alone in Platinum-Resistant or Platinum-Refractory Ovarian Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Avelumab Alone or in Combination With Chemotherapy Versus Chemotherapy Alone in Platinum-Resistant or Platinum-Refractory Ovarian Cancer (JAVELIN Ovarian 200): An Open-Label, Three-Arm, Randomised, Phase 3 Study
Lancet Oncol 2021 Jun 15;[EPub Ahead of Print], E Pujade-Lauraine, K Fujiwara, JA Ledermann, AM Oza, R Kristeleit, IL Ray-Coquard, GE Richardson, C Sessa, K Yonemori, S Banerjee, A Leary, AV Tinker, KH Jung, R Madry, SY Park, CK Anderson, F Zohren, RA Stewart, C Wei, SS Dychter, BJ MonkFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.